Lv11
10 积分 2023-08-21 加入
Splicing factor SF3b as a target of the antitumor natural product pladienolide
2小时前
待确认
Splicing factor SF3b as a target of the antitumor natural product pladienolide
2小时前
待确认
A sustainable approach to universal metabolic cancer diagnosis
2个月前
已完结
SPTLC3 Is Essential for Complex I Activity and Contributes to Ischemic Cardiomyopathy
3个月前
已完结
Platelet-fibrin clot strength and platelet reactivity predicting cardiovascular events after percutaneous coronary interventions
5个月前
已完结
Platelet-fibrin clot strength and platelet reactivity predicting cardiovascular events after percutaneous coronary interventions
5个月前
已完结
Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial
6个月前
已完结
Perioperative Management of Anticoagulant and Antiplatelet Therapy
6个月前
已完结
Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study
7个月前
已完结
皖公网安备34019202002308
